Skip to content

It takes more than medicine...

  • Instagram
  • Vimeo
  • Linkedin

8607 Roberts Drive, Suite 150 Sandy Springs, GA 30350-2237

(770) 518-8272phone    (770) 518-3310fax

8607 Roberts Drive, Suite 150 Sandy Springs, GA 30350-2237


Hemophilia Clinical Scientist Development Grantees


2014-2019 Grantees

Robert F. Sidonio Jr, MD MSc
Assistant Professor of Pediatrics
Vanderbilt University Medical Center, Nashville, Tennessee
Area of Research: Prospective Feasibility Study of the Bleeding Genotype and Phenotype in Hemophilia A Carriers

Sean R. Stowell MD PhD
Post-Doctoral Fellow
Emory University, Atlanta
Area of Research: Characterization of Factors Influencing the Development of Factor VIII Inhibitors

2013–2018 Grantee

Trinh Nguyen of the University, D.O.
Texas Health Science Center
Area of Research: Proper dosing of factor VIII in obese/overweight people with hemophilia A

2010–2015 Grantee

Jordan Shavit, M.D., Ph.D.
University of Michigan, Ann Arbor, Michigan
Area of Research: Novel methods for the identification of genetic and chemical modifiers of hemophilia

2008–2013 Grantees

Michael Callaghan, M.D.
Wayne State University, Detroit, Michigan
Area of Research:  Exploiting the Unfolded Protein Response to Eliminate Inhibitor Antibodies in Hemophilia A

Shannon Meeks, M.D.
Emory University, Atlanta, Georgia
Area of Research:  Mechanisms of Immunogenicity of Factor VIII in a Model Antigen System

2005–2010 Grantees

Amy L. Dunn, M.D.
Emory University, Atlanta, Georgia
Area of research:  Blood Induced Cartilage Changes in a Hemophilia A Murine Model

Miguel A. Escobar, M.D.
University of Texas Health Science Center at Houston
Area of research:  Covalent Inactivation of Antibodies to Factor VIII

2003–2008 Grantees

Suchitra S. Acharya, M.D.
Weill Medical College of Cornell University, New York, New York
Area of research:  Angiogenesis and Hemophilia Synovitis

Paul E. Monahan, M.D.
University of North Carolina at Chapel Hill
Area of research:  Overcoming Limited Clotting Factor Gene Transfer to the Liver Using Adeno-associated Virus (AAV) Vectors Presenting a More Active Molecular Form

Mark T. Reding, M.D.
University of Minnesota, Minneapolis
Area of research:  Immune Response to Factor VIII Following Gene Therapy With Blood Outgrowth Endothelial Cells (BOEC)